Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

002IC - Active Surveillance 2018

Friday, May 18
7:30 AM - 9:30 AM
Location: MCC WEST, 2008

This course will consist of an in-depth summary of the problem of overdiagnosis in contemporary medicine and oncology. Will also examine the role of multiparametric MRI and biomarkers in patient selection and decision making. There will be an update on risk assessment in early prostate cancer, and a discussion of the results of focal therapy, and the relative role of focal therapy vis a vis surveillance.

Learning Objectives:

Laurence H. Klotz

University of Toronto

Laurence Klotz, M.D. is the past Chief of Urology at Sunnybrook HSC and Professor of Surgery at the University of Toronto. He is Chairman of the World Uro-Oncology Federation. Dr. Klotz was the Founding Editor-in-Chief of both the Canadian Journal of Urology and the Canadian Urology Association Journal (CUAJ), and is now Editor Emeritus of the CUAJ. He was the founder and is chairman of the Canadian Urology Research Consortium (CURC).

Dr. Klotz obtained his medical degree from the University of Toronto and completed his residency there. He was a fellow at Memorial Sloan Kettering Cancer Centre in uro-oncology.

Dr. Klotz has led many research studies in prostate cancer, including basic research studies of the role of micronutrients and diet in prostate cancer prevention, translational research, and clinical studies in every facet of prostate cancer.

Dr. Klotz has 350 publications and 5 books, mainly in the field of prostate cancer. He is the Associate Editor of the Journal of Urology responsible for prostate cancer. He serves on the boards of many organizations and journals, including the Society of Urologic Oncology (SUO), Prostate Cancer Canada, the journals Prostate Cancer and Prostatic Diseases, Brazilian Journal of Urology, Italian Journal of Urology, and World Journal of Urology.

He was awarded the Queen’s Jubilee Medal for meritorious public service in 2013, and the University of Toronto Department of Surgery Lister Prize and the SUO Medal in 2014. He received the Order of Canada in 2015 and the Richard Williams Award from the AUA for ‘oustanding contributions in the field of prostate cancer over the last decade’ in 2016. He is an Honorary Member of the AUA. He received the Harold Warwick Award from the Canadian Cancer Society in 2015, and the University of Toronto lifetime achievement award in 2017.

Presentation(s):

Send Email for Laurence Klotz

Mark Emberton

University College London

Mark Emberton
University College London (UCL), London, UK.

Mark Emberton is Professor of Interventional Oncology at UCL. He is an Honorary Consultant Urologist at University College Hospitals NHS Foundation Trust and Founding Pioneer of The Charity Prostate Cancer UK.
Professor Emberton’s clinical research is aimed at improving the diagnostic and risk stratification tools and treatment strategies for prostate cancer (PCa); he specialises in the implementation of new imaging techniques, nanotechnologies, bio-engineering materials and non-invasive treatment approaches, such as high intensity focused ultrasound and photo-dynamic therapy.
Professor Emberton’s research has been published in >300 peer-reviewed scientific papers in journals including BMJ, Lancet Oncology and European Urology. He has also contributed to the development of guidelines for the management of PCa and lower urinary tract symptoms, published by the International Society of Geriatric Oncology and the European Association of Urology.
Professor Emberton is also involved in teaching within UCL and the London and South East Urological Training scheme and was appointed Dean of UCL Faculty of Medical Sciences in 2015. In addition to being a member of various urological and medical organisations (American Association of GenitoUrinary Surgeons, British Association of Urological Surgeons, European Association of Urology). He is a founding partner of London Urology Associates.

Presentation(s):

Send Email for Mark Emberton

Ian M. Thompson

Professor Emeritus, University of Texas Health Science Center San Antonio

Ian M. Thompson, Jr, MD received his undergraduate degree from West Point and M.D. from Tulane University. After a Residency in Urology in San Antonio, he completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. After retirement from the US Army in 2000, he served as is Professor of Urology and then Director of the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio, a National Cancer Institute designated Cancer Center. After retiring from UT in 2016, he was appointed President, CHRISTUS Santa Rosa Medical Center Hospital and Regional VP of Oncology.
Dr. Thompson has published over 600 scientific papers, several dozen book chapters, and has edited six textbooks in medicine and surgery. He has served as Chair of the Early Detection Research Network of the National Cancer Institute, Chair of the Genitourinary Committee of the Southwest Oncology Group, Chair of the Urology Residency Review Committee of ACGME and President of the Society of Urologic Oncology. He completed his service on Subcommittee A (Cancer Centers) of the National Cancer Institute and thereafter was appointed to the NCI's Board of Scientific Advisors.
Dr. Thompson has overseen several large-scale clinical trials in prostate and other cancers. He is PI of the San Antonio Center for Biomarkers of Risk of Prostate Cancer, a cohort study, with over 17 years of follow up, following over 3,700 men for development of prostate cancer. He was the Principal Investigator of the Prostate Cancer Prevention Trial, Principal Investigator of S8794 (Adjuvant Radiotherapy for pT3 Prostate Cancer), and co-PI of SELECT.
Dr. Thompson retired as a Colonel from the U.S. Army in 1999.. He served in Saudi Arabia and Iraq as a General Surgeon in a Combat Support Hospital during Operation Desert Storm/Shield.

Presentation(s):

Send Email for Ian Thompson


Assets

002IC - Active Surveillance 2018



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Active Surveillance 2018